COMMUNIQUÉS West-GlobeNewswire
-
Cannara obtient la qualification OTCQX et annonce la publication de ses résultats financiers du premier trimestre de l'exercice 2026 le 26 janvier 2026
14/01/2026 -
J-Star Signs MOU with PSSB to Provide Resins for Batteries
14/01/2026 -
Alira Health Announces Bill Achtmeyer and George G. Montgomery as Members of Board of Directors
14/01/2026 -
COEFFEX AND BEC SEARCH PARTNER TO DELIVER DATA-DRIVEN “WHOLE PERSON” HIRING AND LEADERSHIP DEVELOPMENT TO LIFE SCIENCES AND HEALTHCARE INDUSTRIES
14/01/2026 -
Clearmind Medicine Announces Successful Completion of Treatment in All Patients of the Second Cohort in Ongoing Phase I/IIa Clinical Trial for CMND-100
14/01/2026 -
Nanox Expands in Europe with New Nanox.ARC Distribution Engagement in Serbia, Montenegro, and Bosnia and Herzegovina
14/01/2026 -
SL BIO Ltd. and Horizon Space Acquisition II Corp. Announce Registration Statement Effectiveness and Extraordinary General Meeting Date to Approve Business Combination
14/01/2026 -
RenovoRx to Participate in AlphaNorth Capital Event, January 16-18, 2026
14/01/2026 -
SELLAS Life Sciences Enters Agreement with IMPACT-AML to Expand SLS009 Clinical Program into Europe
14/01/2026 -
LENZ Therapeutics and Sarah Jessica Parker announce the launch of “Make it VIZZable”, the VIZZ consumer campaign
14/01/2026 -
RetinalGenix Reports on its Science and Mission in Light of New AI-Driven Retinal Mapping Study
14/01/2026 -
Verano Strengthens National Product Portfolio in Industry’s Fastest-Growing Category with Launch of Swift Lifts as Standalone Pre-roll Brand
14/01/2026 -
Human Appeal Concludes First-Ever U.S. Winter Coat Drive
14/01/2026 -
Inside information: Orion provides outlook for 2026 and estimates that the annual Nubeqa® net sales recorded by Orion has potential to exceed EUR 1 billion in the future
14/01/2026 -
New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS
14/01/2026 -
De nouvelles données renforcent l’engagement d’Ipsen à proposer des solutions et à combler les lacunes de prise en charge dans les maladies neurologiques lors du congrès TOXINS
14/01/2026 -
HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet
14/01/2026 -
BriaCell Therapeutics Announces Pricing of $30 million Public Offering
14/01/2026 -
Aqua free enters the B2C market with “Shower2go”: a portable travel shower for safer showering on the go – helping to reduce exposure to Legionella
13/01/2026
Pages